Related Experiment Video
Updated: Aug 22, 2026

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats
Published on: March 22, 2024
New insights into the management of bleeding disorders
1Servicio de Hemoterapia y Hemostasia, CDB, Hospital Clinic, Barcelona, Spain. escolar@medicina.ub.es
Abstract:
The Novo Nordisk European Symposium on New Insights into the Management of Bleeding Disorders was held April 23-24, 2004, in Madrid, Spain. More than 200 specialists in the management of congenital and acquired bleeding disorders attended the different sessions. During the symposium, new medical indications for the use of human recombinant activated factor VII (rFVIIa, eptacog alfa activated) were presented. Rationale for new clinical trials and updates on registry for emerging indications were also discussed.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...